Public Event Detail
Insmed stock hits 52-week low at 90.85 USD
Public historical observation from the Merrowstone archive. This page shows event-level context only. Accepted assertions, evidence lineage, and relationship intelligence remain part of the premium research layer.
Historical observations only. No forecasts, recommendations, buy/sell ratings, or portfolio advice.
2026-06-10AAPLAppleAlpha Vantage Newsearnings
Event summary
Insmed Inc. (INSM) stock has fallen to a 52-week low of $90.85, a significant drop despite the company reporting better-than-expected Q1 2026 earnings and revenue. Analysts maintain a "Strong Buy" consensus, projecting over 100% upside potential and anticipating sales growth, while also acknowledging competitive risks.
Attached public signals
revenue-accelerationConfidence: 0.80demand-strengthConfidence: 0.67guidance-reaffirmedConfidence: 0.56
Observed outcomes
7d returnPending
30d returnPending
90d returnPending
Relative 90d returnPending